NCT00833989 - Safety Escalating Repeat IV, in Stroke Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Ischaemic Attack, Transient

Interventions

DRUG

GSK249320

I.V. infusion

DRUG

PLACEBO

Placebo

Trial Locations (15)

29223

GSK Investigational Site, Celle

30625

GSK Investigational Site, Hanover

45122

GSK Investigational Site, Essen

48201

GSK Investigational Site, Detroit

50937

GSK Investigational Site, Cologne

55131

GSK Investigational Site, Mainz

65199

GSK Investigational Site, Wiesbaden

80524

GSK Investigational Site, Fort Collins

89081

GSK Investigational Site, Ulm

97239

GSK Investigational Site, Portland

90095-6984

GSK Investigational Site, Los Angeles

92868-4280

GSK Investigational Site, Orange

M4N 3M5

GSK Investigational Site, Toronto

H3T 1E2

GSK Investigational Site, Montreal

04103

GSK Investigational Site, Leipzig